Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2026-06-30 to 2026-07-07
| Company | Round | Amount | Announced | Role | Verified |
|---|---|---|---|---|---|
FORE Biotherapeutics A cancer therapeutics company developing targeted treatments for hard-to-treat tumours | Series D+ ext. | n/a | 2026-07-07 | [ PART ] | 3 |
Flare Therapeutics A biotech startup targeting transcription factors | Series C | $85M | 2026-06-30 | [ PART ] | 5 |